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Incidence and clinical significance of distal
embolization during percutaneous interventions
involving the superficial femoral artery
Russell C. Lam, MD, Syed Shah, MD, Peter L. Faries, MD, James F. McKinsey, MD, K. Craig Kent,
MD, and Nicholas J. Morrissey, MD, New York, NY
Objective: Distal embolization of plaque or thrombus may cause organ ischemia following percutaneous peripheral
interventions. The purpose of this study was to evaluate the incidence and clinical significance of particulate embolization
during percutaneous superficial femoral artery (SFA) intervention by monitoring with continuous Doppler ultrasound.
The rate and timing of embolization at various phases of intervention such as guidewire crossing, balloon angioplasty,
stent deployment, and directional atherectomy were analyzed and compared.
Methods: Sixty patients underwent SFA intervention. Of these 60 patients, 10 patients underwent percutaneous
transluminal angioplasty (PTA) alone, 40 patients underwent PTA with stenting, and 10 patients underwent plaque
excision with the SilverHawk atherectomy device (8) or Spectranetics excimer laser (2) with or without additional PTA
or stent placement. A 4-MHzDoppler probe was used for continuous monitoring in the ipsilateral popliteal artery. Distal
embolization was registered as embolic signals (ES). ES were quantitatively assessed during critical portions of the
procedure including guidewire crossing, balloon angioplasty, stent deployment and/or atherectomy. ES during different
phases of intervention were compared using analysis of variance (ANOVA).
Results: ES was noted in every patient during wire crossing, angioplasty, stent deployment and atherectomy. The average
number of ES noted during guidewire crossing was 8, PTA was 12, stent deployment was 28, SiverHawk atherectomy
was 49, and Spectranetics excimer laser was 51. The frequency of ES was statistically higher during stent deployment vs
wire crossing or balloon angioplasty but equivalent to that generated by plaque excision. ES was observed more frequent
during balloon angioplasty than during wire crossing. In one patient who was treated with the excimer laser, a single
runoff vessel was occluded with embolic debris but patency was restored angiographically after thrombolysis. The patient
went on to require below knee amputation. During follow-up, all patients with claudication reported improved
symptoms and those with ulcers or gangrene demonstrated healing. The average increase in ankle-brachial index
following intervention was 0.31.
Conclusion:While ESwere recorded at each step of SFA intervention, the frequency was greatest during stent deployment.
Despite the frequency of these events, only one patient developed angiographically and clinically significant embolization.
Thus, our findings do not support the routine use of protection devices during percutaneous SFA intervention. (J Vasc
Surg 2007;46:1155-9.)Endovascular therapy for occlusive disease of the super-
ficial femoral artery (SFA) has gained acceptance as a pri-
mary treatment modality for peripheral arterial disease
(PAD).1,2 Surgery remained the gold standard for com-
plete SFA occlusion or concomitant common femoral ar-
tery involvement. Percutaneous interventions have a num-
ber of potential advantages, including a shorter
hospitalization, ability to use local anesthesia, and less
perioperative morbidity.3 Endovascular treatment of this
arterial segment presents a particular technical challenge, as
the extent of disease varies from lesions that are short, focal,
and stenotic to long, diffuse, and occluded. Over the past
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including simple balloon angioplasty, subintimal angio-
plasty, cryoplasty, stenting, and directional atherectomy.
While there is considerable debate about the optimal
percutaneous treatment modality for peripheral arterial dis-
ease, embolization of the distal arteries is a potential com-
plication that may produce worsening ischemia or limb
loss. The incidence of distal embolization as determined by
angiographic or clinical manifestations has been estimated
to range from 4% to 5% for peripheral interventions. how-
ever, the true incidence of asymptomatic embolization is
likely higher.3-8 Thus far, attempts at measuring emboliza-
tion during peripheral arterial interventions have been few
and with small numbers of patients.9-11 The purpose of this
prospective study was to evaluate the incidence of distal
embolization during percutaneous SFA intervention using
continuous transcutaneous Doppler ultrasound. We quan-
tified the rate of embolization at various phases of interven-
tion, such as during guidewire crossing, balloon angio-
plasty, stent deployment, and directional atherectomy with
either the SilverHawk (FoxHollow Technologies, Red-
wood City, Calif) device or the Spectranetics excimer laser
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Colo), and analyzed angiographic and clinical sequelae of
these events. Finally, rates of embolization for lesions of
different anatomic severity as outlined by the Transatlantic
Inter-Society Consensus (TASC) classification or calcifica-
tion were compared.
METHODS
Patients. From December 2005 to December 2006,
60 patients who underwent percutaneous SFA interven-
tions provided informed consent and were enrolled in this
study under institutional IRB approval. Inclusion criteria
were a primary SFA stenosis or occlusion and aminimum of
one vessel runoff. Patients undergoing concomitant tibial
intervention were not excluded; however, embolic detec-
tion was valid only for SFA or above knee popliteal lesions,
given the location of our probe. Patients needed to have a
patent popliteal segment at the level of the knee in order for
there to be successful insonation at that level. Data were
accumulated prospectively for analysis. Preoperative imag-
ing consisted of lower extremity arterial pressures, ankle-
brachial index (ABI) measurements and pulse volume re-
cordings in all cases. Arterial duplex and magnetic
resonance angiography were performed in selective cases
based on the surgeon’s preference. No patient was ex-
cluded based upon anatomic characteristics that were noted
on preoperative imaging. Choice of intervention was per-
formed at the discretion of the operating surgeon. There
was no specific protocol defining the use of predilation,
routine stenting, No patients were lost to follow-up. All
patients were interviewed and examined postoperatively
and at 30 days postintervention. ABIs were repeated at
30-days postintervention and were compared with prein-
tervention values.
Anatomic evaluation. Digital subtraction angio-
grams of all 60 patients were available for evaluation. SFA
calcification was assessed on orthogonal views and evalu-
ated as absent or mild if there was no or a trace calcium
shadow, moderate if there was a calcium shadow on or
50% of the vessel diameter, and severe if the calcium shadow
outlined 51% to 100% of the vessel. Lesions were classified
according to the TASC criteria23 as follows:
TASC A: Single stenosis  or  3 cm. not at the origin of
the superficial femoral or distal popliteal artery.
TASC B: Single stenosis or occlusion 3 to 5 cm, not
involving the distal popliteal or multiple stenoses or
occlusions each  3 cm long.
TASC C: Single stenosis  5 cm or multiple lesions each 3
to 5 cm long.
TASCD: Complete common femoral or superficial femoral
artery occlusions.
Doppler evaluation. Intraoperative monitoring was
continuous and all critical portions of the procedure were
recorded. All evaluations were performed by the same
ultrasonographer and the senior author (NJM). A 4 -MHz
pulse wave transcranial Doppler (TCD) system (Multigon
Industries, Yonkers, NY) was used to insonate the ipsilat-eral popliteal artery. The probe was secured in place in the
posterior popliteal fossa. The presence of the probe did not
interfere with or necessitate modification of standard endo-
vascular techniques. Instrument power and gain settings
were adjusted to provide an optimal signal-to-noise ratio
and achieve a constant analog signal recording level. The
Doppler signal was recorded continuously on digital audio
tape (Sony TCD-D10 ProII, Sony Corporation, New York,
NY). A 6 decibel (dB) intensity threshold above peak
background intensity was considered indicative of an em-
bolic signal (ES).24 Differentiation between air and partic-
ulate embolism based on ES intensity measurements was
not attempted because the sensitivity of the TCD device in
this study does not permit such differentiation. Number of
ES were calculated at each procedure and the total number
for each intervention type (wire crossing, angioplasty, tent
deployment, atherectomy) determined per patient. Com-
parison between different types of angioplasty (predilation,
post-stent deployment) did not reveal significant difference
in ES between these subtypes and further analysis based on
this was not performed.
Statistical analysis. ES counts were not normally dis-
tributed and were represented as averages. The rate of ES
during different phases of intervention were quantified and
compared using analysis of variance (ANOVA) with statis-
tical significance achieved at P  .05. In addition, we
compared ES between different TASC and calcification
categories using ANOVA. SAS statistical software was used.
RESULTS
Sixty patients were enrolled in the present study. Thir-
ty-eight patients (63%) were men and 22 patients (37%)
were women. The average age was 70 years (range 45 to 82
years). The technical success rate in this study was 100%.
The indications for SFA intervention included disabling
claudication in 34 patients (56.7%), rest pain in 10 patients
(16.7%), ischemic ulceration in 8 patients (13.3), and gan-
grene in 8 patients (13.3%) (Table I). Of these 60 patients,
10 patients underwent percutaneous transluminal angio-
plasty (PTA) alone, 40 patients underwent PTA with stent-
ing, and 10 patients underwent plaque excision with the
SilverHawk atherectomy device (8) or Spectranetics exci-
mer laser (2) with or without additional PTA or stent
placement. Anatomic evaluation revealed that 41 patients
had severe, 17 patients had moderate, and 2 patients had
mild calcification at the site of arterial treatment. These
Table I. Clinical indications for percutaneous SFA
intervention
Indications for SFA intervention n  number of patients
Disabling claudication 34
Rest pain 10
Ischemic ulcers 8
Gangrene 8
SFA, Superficial femoral artery.lesions were characterized anatomically by TASC classifica-
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corded from the preintervention angiography runs (Table
III).
ES was noted in each patient while crossing of the
lesion with a guidewire, as well as during balloon angio-
plasty, stent deployment, and/or plaque excision (Fig).
The frequency of ES was significantly higher during stent
deployment than during wire crossing or balloon angio-
plasty. When more than one stent was deployed, there were
no significant differences in ES detected during the first
stent deployment vs subsequent stents. The number of ES
was significantly higher during balloon angioplasty than
wire crossing. The number of ES during stent-deployment
was not significantly different than that seen during Silver-
Hawk plaque excision or during laser atherectomy (Table
IV). There were no significant differences in ES seen be-
tween TASC classifications (Table V). Moreover, severity
of calcification did not predict the frequency of ES, al-
though more cases in each category of calcification are
needed to conclusively state the effect of vessel calcificaton
on ES frequency. During plaque excision with the Silver-
Hawk device, ES occurred during device passage but also
during the quiescent periods between passages while the
device was outside of the patient. We did not note any
difference in the rate of ES for predilation angioplasty vs
Fig. Mean embolic signal frequency during different phases of
intervention.
Table II. Distribution of lesions based on TASC
classification
TASC Classification TASC A TASC B TASC C TASC D
Number of lesions 8 16 27 9
Table III. Status of runoff vessels in patients undergoing
percutaneous SFA intervention
Number of runoff vessels
1 2 3
Number of patients 8 32 20
SFA, Superficial femoral artery.postdilation of an implanted stent. Postdilation of onepatient had angiographic evidence of loss of a solitary
anterior tibial runoff artery (1.7%). This patient had been
treated with laser atherectomy and the anterior tibial artery
was reopened after infusion of TPA. The number of ES in
this patient was statistically identical to number observed
with the other laser atherectomy and SilverHawk patients
in this series. The patient presented initially with a severely
ischemic foot which had already suffered sensory loss and
somemotor compromise. In spite of angiographic evidence
for restoration of flow in the anterior tibial artery and an
increase in ABI, the patient eventually underwent a below
the knee amputation. There was no clinical evidence of
digital embolization in this patient or in any of the patients
evaluated in this series.
Patients were followed for an average 12months (range
6 to 18 months). All patients suffering from claudication
reported an improvement in symptoms at the time of
follow-up visit. The average ABI preintervention was 0.62
and postintervention increased to 0.93 for an average im-
provement in ABI of the treated limb of 0.31  0.2. All
patients with gangrenous digits healed toe amputations and
all ulcers demonstrated some degree of healing following
intervention, although, perhaps due to short follow-up in
some cases, some wounds remain open.
DISCUSSION
Distal protection systems are becoming standard prac-
Table IV. Results of analysis of variance (ANOVA) for
embolic signals (ES) during various phases of SFA
intervention
Average ES P value
Stent deployment 30.9 .001
Balloon angioplasty 16.38
Average ES P value
Stent deployment 30.9 .001
Guidewire 8.9
Average ES P value
Balloon angioplasty 16.38 .001
Guidewire 8.9
SFA, Superficial femoral artery.
Table V. Difference in ES frequency based on TASC
classification, analyzed with ANOVA
Summary
Groups Average P value between groups
A 63 .965
B 65
C 61
D 69
ANOVA, Analysis of variance.tice for carotid15 and coronary artery interventions and,
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ventions has increased. However, no evidence exists to
support the routine use of protection devices for percuta-
neous treatment of peripheral vascular disease, and there
are currently no data available that define which patients
might be at high risk for embolization. Nonetheless, arti-
cles in non-peer reviewed publications have raised the
question of whether distal protection might be useful dur-
ing SFA angioplasty.12 Conversely, embolic protection de-
vices are expensive and they may cause arterial injury. In
order to address this issue, we felt as a first step that it would
be useful to quantify the incidence and significance of
embolization during SFA angioplasty.
Previous reports of percutaneous carotid interventions
revealed that multiple embolic particles often classified on
Doppler ultrasound as embolic signals were generated from
plaques and that these particles were associated with each
phase of endovascular intervention.13-16 Rates of detection
of ES varied during the phases of carotid intervention and
occurred less frequently in the presence of distal protec-
tion.15 We used methods similar to those employed in these
carotid studies to define ES in patients treated with percu-
taneous peripheral vascular interventions. Based on the
routine use of TCD for ES detection in the carotid litera-
ture, we felt comfortable that our methodology was satis-
factory and that ES could be reliably reported.
In all 60 patients studied in our series, ES were detected
in the ipsilateral popliteal artery during all critical phases of
the SFA and proximal popliteal interventions. We found
clear differences in ES rates between different phases of
intervention with stent deployment and plaque excision
resulting in the highest number of ES followed by angio-
plasty followed by wire crossing. We did not find differ-
ences in ES rates related to lesion type. Surprisingly, neither
TASC classification nor the degree of calcification influ-
enced the frequency of embolic events. These findings
suggest that lesion characteristics may not predict emboli-
zation or their clinical sequelae after percutaneous interven-
tion. The data with respect to calcification may be mislead-
ing since there were only a few patients with mild
calcification for comparison. It is possible that if this study
included a larger number of patients with mild or no
calcification, a difference might have been realized.
In our single case of angiographically evident emboli-
zation, most likely a subacute thrombus from a chronic
severe plaque was dislodged. Although the TCD is an
instrument that primarily quantifies microembolization, it
is important to realize that during peripheral vascular inter-
ventions thrombus or a large piece of atherosclerotic plaque
can also pass downstream. This patient’s presenting symp-
toms were acute and severe, likely related to that fact that he
had only single vessel runoff. Embolization most likely
occurred during repeated passages of the laser catheter for
treatment. Our ability to treat the embolus with thrombol-
ysis suggests it was largely thrombus. It is possible in this
one case, that a distal protection device would have pre-
vented this untoward complication. This patient was
treated with an excimer laser atherectomy device.However,stent placement and atherectomy were also associated with
rates of ES that were equivalent to laser atherectomy.
Unfortunately, we were not able with this study to deter-
mine factors that would predict which patients should be
treated with filter devices.
Konig and colleagues used a distal protection device in
11 cases of SFA intervention.11 They collected debris in the
filter but typically this was fibrin and red cells. The authors
also typically observed macroemboli around and distal to
the filter, which were not retrieved by the filter. In all of
their cases, there was a significant decrease in flow through
the filter related to debris obliterating its pores. Interest-
ingly, they did not heparinize their patients until PTA was
performed. Most of the debris they collected appeared to
be thrombotic and may have been related to a lack of
anticoagulation prior to intervention.11 Other investigators
have evaluated the incidence of embolization associated
with peripheral interventions. Kudo et al used Doppler
techniques to analyze the incidence of ES during different
facets of iliac artery intervention; comparing the different
phases such as passage of the guidewire, balloon angio-
plasty, and stent deployment.9 In their series of 10 cases,
the authors reported the incidence of ES was greatest
during stent deployment vs guidewire passage or balloon
angioplasty a finding that was similar to ours.
Studies have demonstrated that disruption of plaque
after carotid angioplasty sets in motion a cascade of events,
including the release of plaque debris, the deposition of
platelets, and the formation of thrombus.4,5,15 The emboli
detected after angioplasty of mature plaques is typically a
combination of atherosclerotic debris, cholesterol, calcified
material, and platelet emboli.18,19 We made no attempt in
this study to determine size of particles although methods
and devices exist that can provide semiquantitative assess-
ment of ES properties.17 With only one clinically significant
case of embolization, it is unlikely that analysis of particle
characteristics would provide insight into the risk of clini-
cally relevant events in a series of this size.
Plaque excision with the SilverHawk atherectomy de-
vice is currently employed as an alternative or adjunct to
angioplasty and stenting in endovascular SFA interven-
tions. To avoid distal embolization, these devices have a
built in chamber for the collection of the excised plaque for
later removal. However, Suri et al21 and Zeller et al22 also
noted the presence of distal emboli during femoropoliteal
plaque excision with the SilverHawk atherectomy device in
their series.19,20 We similarly detected emboli during our
SilverHawk cases. Interestingly, numerous emboli were
detected during the period between passes of the plaque
excision catheter, while the device was quiescent. Such a
finding may reflect embolization of debris from a trauma-
tized, disrupted surface. In spite of these findings, we saw
no clinically or angiographically significant embolization
during SilverHawk treatment. Since we enrolled only eight
patients undergoing plaque excision, our number may be
too low to make any definitive conclusions.
This study has several limitations. A theoretical limita-
tion of this study was the lack of an objective correlation
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ultrasound and actual proof of embolization since distal
protection devices were not employed in this study for
reasons discussed. Although we did enroll 60 patients, the
sample population was relatively small considering the vari-
ables present in these types of patients. Although an at-
tempt was made to include in this series all patients under-
going intervention, some patients were excluded because of
patient refusal or scheduling problems. In spite of these
limitations, the fact remains that we consistently detected
emboli in all patients undergoing SFA intervention with
only one case of clinically significant embolization. These
results indicate that although embolization occurs rou-
tinely during percutaneous SFA intervention, clinical se-
quelae are rare. It seems at least in the absence of further
data, routine use of embolic protection in these patients is
not warranted.
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